Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024

The global semi-solid dosage contract manufacturing market size was valued at USD 17.57 billion in 2023 and is projected to grow at a CAGR of 11.12% from 2024 to 2030. The rising demand for patient-friendly medications coupled with growing prevalence of chronic diseases such as skin diseases, arthritis, and pain management aids the market growth. Moreover, there is a growing demand for manufacturing outsourcing due to its cost-effectiveness. Furthermore, regulatory compliance and quality assurance, technological advancements including innovation in formulation technologies, are likely to boost their demand over the forecast period.

The high prevalence of chronic conditions such as skin diseases, arthritis and the requirement for pain management solutions due to the ageing population around the world is a major factor for the market growth. With an estimated 1.8 billion people affected by over 3,000 types of skin conditions at any given time, according to the World Health Organization, there's a massive demand for effective treatments. The U.S. population is experiencing a significant shift towards aging. According to the January 2024 fact sheet by the Population Reference Bureau, the number of Americans aged 65 and older is expected to surge from 58 million in 2022 to 82 million by 2050, representing a substantial 47% increase. Additionally, the proportion of the total population comprised of individuals aged 65 and older is projected to rise from 17% to 23%, marking the oldest age distribution in U.S. history.

In addition, according to the Global Burden of Disease Study 2021, skin diseases rank as the eighth leading cause of global health burden. Semi-solid dosage forms, such as creams and ointments, are a preferred method of administration for many skin diseases, offering a convenient and mess-free application. This surge in demand for skin condition and pain management treatments is propelling the growth of the market, as pharmaceutical companies seek out partners with the expertise to produce these medications efficiently and in large quantities. Further, according to the CDC report covering the period from 2019 to 2021, arthritis was most prevalent in 17.9% of men and 24.2% of women in the U.S. (NHIS).

Additionally, contract manufacturing enables pharmaceutical companies to access manufacturing capabilities, adhere to regulatory standards, and support to minimize costs associated with in-house production facilities. Strategic collaborations between pharmaceutical companies and contract manufacturers are instrumental in the efficient production of semi solid dosage forms, facilitating faster market entry for drugs further optimization of existing formulations. Setting up and maintaining in-house production lines for semi-solid medications requires substantial investments. This includes specialized equipment for mixing, filling, and packaging these dosage forms, as well as the expertise to operate them efficiently. By partnering with a contract manufacturer (CMO), pharmaceutical companies can bypass these upfront costs and ongoing maintenance expenses. CMOs specialize in semi-solid production and have economies of scale, allowing them to leverage their expertise and equipment for multiple clients.

The semi-solid dosage contract manufacturing market is witnessing a surge of innovative developments, driven by advancements in formulation technology and a growing focus on patient-centric solutions. Formulation innovations include the use of nano and micronized particles to enhance bioavailability, as well as sophisticated particle size distribution techniques to optimize stability and performance. Manufacturers are also prioritizing patient compliance, with the introduction of user-friendly packaging designs and self-administration features. Strategic collaborations between pharmaceutical companies and contract manufacturers are enabling efficient production and faster market entry of these specialized formulations.

While the market is primarily driven by the growing demand for pharmaceutical creams, ointments, and gels, CMOs can leverage their expertise in these semi-solid dosage forms to cater to the cosmetics industry as well. This allows them to expand their client base and optimize production lines. Furthermore, the growing consumer interest in topical skincare products creates additional opportunities for CMOs to partner with cosmetic companies in developing and manufacturing innovative creams, serums, and lotions. This synergy between the pharmaceutical and cosmetic sector helps to fuel the overall growth of the market.

Furthermore, the demand for personalized medicine is fueling the development of customized semi-solid dosage forms tailored to individual needs. Absorption-enhancing ingredients and novel excipients are also being leveraged to improve the efficacy and bioavailability of these topical treatments. These multifaceted innovations are transforming the semi-solid dosage form market, offering more effective, convenient, and personalized solutions for a wide range of skin, eye, and chronic pain conditions.

Global Semi-solid Dosage Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global semi-solid dosage contract manufacturing market report on the basis of type, product, end use, company size and region:

Type Outlook (Revenue, USD Million, 2018 - 2030)
Topical
Transdermal
Oral
Product Outlook (Revenue, USD Million, 2018 - 2030)
Creams
Ointments
Gels
Lotions
Pastes
Others
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical Companies
Cosmeceutical Companies
Others
Company Size Outlook (Revenue, USD Million, 2018 - 2030)
Large Size Companies
Medium & Small Size Companies
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Product Code: GVR-4-68040-345-3

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Product
- 1.2.3. End Use
- 1.2.4. Company Size
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Semi-solid Dosage Contract Manufacturing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising demand for patient-friendly medications
  - 3.2.1.2. Growing prevalence of chronic diseases
  - 3.2.1.3. Growing demand of manufacturing outsourcing
  - 3.2.1.4. Regulatory Compliance
  - 3.2.1.5. Technological advancements
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Quality control challenges
3.3. Semi-solid Dosage Contract Manufacturing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Semi-solid Dosage Contract Manufacturing Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Semi-solid Dosage Contract Manufacturing Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Topical
- 4.5.1. Topical market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Transdermal
- 4.6.1. Transdermal market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Oral
- 4.7.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Semi-solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

5.1. Product Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Semi-solid Dosage Contract Manufacturing Market by Product Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Creams
- 5.5.1. Creams market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Ointments
- 5.6.1. Ointments market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Gels
- 5.7.1. Gels market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Lotions
- 5.8.1. Lotions market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Pastes
- 5.9.1. Pastes market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Other
- 5.10.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Semi-solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Semi-solid Dosage Contract Manufacturing Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Pharmaceutical companies
- 6.5.1. Pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Cosmeceutical companies
- 6.6.1. Cosmeceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Other
- 6.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Semi-solid Dosage Contract Manufacturing Market: Company Size Estimates & Trend Analysis

7.1. Company Size Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Semi-solid Dosage Contract Manufacturing Market by Company Size Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Large Size Companies
- 7.5.1. Large size companies market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Medium & Small Size Companies
- 7.6.1. Medium & small size companies market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Others
- 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Semi-solid Dosage Contract Manufacturing Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Regulatory framework
  - 8.4.2.3. Competitive scenario
  - 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Regulatory framework
  - 8.4.3.3. Competitive scenario
  - 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Regulatory framework
  - 8.4.4.3. Competitive scenario
  - 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory Scenario
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory Scenario
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Regulatory Scenario
  - 8.5.4.3. Competitive scenario
  - 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Regulatory Scenario
  - 8.5.5.3. Competitive scenario
  - 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Regulatory framework
  - 8.5.6.3. Competitive scenario
  - 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Regulatory framework
  - 8.5.7.3. Competitive scenario
  - 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.8. Sweden
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Regulatory framework
  - 8.5.8.3. Competitive scenario
  - 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.9. Denmark
  - 8.5.9.1. Key country dynamics
  - 8.5.9.2. Regulatory Scenario
  - 8.5.9.3. Competitive scenario
  - 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory Scenario
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory Scenario
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory Scenario
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Australia
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory Scenario
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. South Korea
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory Scenario
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Regulatory Scenario
  - 8.6.7.3. Competitive scenario
  - 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Regulatory Scenario
  - 8.7.3.3. Competitive scenario
  - 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory Scenario
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Regulatory Scenario
  - 8.8.3.3. Competitive scenario
  - 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Regulatory Scenario
  - 8.8.4.3. Competitive scenario
  - 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key country dynamics
  - 8.8.5.2. Regulatory framework
  - 8.8.5.3. Competitive scenario
  - 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company market share analysis, 2023
9.4. Company Profiles
- 9.4.1. Lonza Group Ltd.
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Others benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Lubrizol Life Science
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Others benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Cambrex Corporation
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Others benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Contract Pharmaceuticals Limited
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Others benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Bora Pharmaceutical CDMO
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Others benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. Ascendia Pharmaceuticals
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Others benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. Pierre Fabre group
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Others benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Piramal Pharma Solutions
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Others benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. DPT Laboratories, LTD
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Others benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. MedPharm Ltd
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Others benchmarking
  - 9.4.10.4. Strategic initiatives
- 9.4.11. Catalent, Inc.
  - 9.4.11.1. Company overview
  - 9.4.11.2. Financial performance
  - 9.4.11.3. Others benchmarking
  - 9.4.11.4. Strategic initiatives
- 9.4.12. Recipharm AB
  - 9.4.12.1. Company overview
  - 9.4.12.2. Financial performance
  - 9.4.12.3. Others benchmarking
  - 9.4.12.4. Strategic initiatives
- 9.4.13. Aenova Group
  - 9.4.13.1. Company overview
  - 9.4.13.2. Financial performance
  - 9.4.13.3. Others benchmarking
  - 9.4.13.4. Strategic initiatives
- 9.4.14. Almac Group
  - 9.4.14.1. Company overview
  - 9.4.14.2. Financial performance
  - 9.4.14.3. Others benchmarking
  - 9.4.14.4. Strategic initiatives
- 9.4.15. Ajinomoto Bio-Pharma Services
  - 9.4.15.1. Company overview
  - 9.4.15.2. Financial performance
  - 9.4.15.3. Others benchmarking
  - 9.4.15.4. Strategic initiatives

Product Code: GVR-4-68040-345-3

List of Tables

Table 1 List of abbreviation
Table 2 North America semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
Table 3 North America semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 4 North America semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 5 North America semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 6 North America semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 7 U.S. semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 11 Canada semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 12 Canada semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 13 Canada semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 14 Canada semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 15 Mexico semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 16 Mexico semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 17 Mexico semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 18 Mexico semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 19 Europe semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
Table 20 Europe semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 21 Europe semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 22 Europe semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 23 Europe semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 24 Germany semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 25 Germany semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 26 Germany semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 27 Germany semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 28 UK semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 29 UK semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 30 UK semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 31 UK semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 32 France semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 33 France semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 34 France semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 35 France semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 36 Italy semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 37 Italy semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 38 Italy semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 39 Italy semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 40 Spain semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 41 Spain semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 42 Spain semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 43 Spain semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 44 Denmark semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 45 Denmark semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 46 Denmark semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 47 Denmark semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 48 Sweden semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 49 Sweden semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 50 Sweden semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 51 Sweden semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 52 Norway semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 53 Norway semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 54 Norway semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 55 Norway semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 56 Asia Pacific semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 58 Asia Pacific semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 59 Asia Pacific semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 60 Asia Pacific semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 61 China semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 62 China semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 63 China semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 64 China semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 65 Japan semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 66 Japan semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 67 Japan semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 68 Japan semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 69 India semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 70 India semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 71 India semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 72 India semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 73 South Korea semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 74 South Korea semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 75 South Korea semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 76 South Korea semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 77 Australia semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 78 Australia semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 79 Australia semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 80 Australia semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 81 Thailand semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 82 Thailand semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 83 Thailand semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 84 Thailand semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 85 Latin America semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 86 Latin America semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 87 Latin America semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 88 Latin America semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 89 Brazil semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 90 Brazil semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 91 Brazil semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 92 Brazil semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 93 Argentina semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 94 Argentina semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 95 Argentina semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 96 Argentina semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 97 MEA semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
Table 98 MEA semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 99 MEA semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 100 MEA semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 101 MEA semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 102 South Africa semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 103 South Africa semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 104 South Africa semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 105 South Africa semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 110 UAE semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 111 UAE semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 112 UAE semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 113 UAE semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
Table 114 Kuwait semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 115 Kuwait semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
Table 116 Kuwait semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
Table 117 Kuwait semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Semi-solid dosage contract manufacturing market: market outlook
Fig. 14 Semi-solid dosage contract manufacturing competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Semi-solid dosage contract manufacturing market driver impact
Fig. 20 Semi-solid dosage contract manufacturing market restraint impact
Fig. 21 Semi-solid dosage contract manufacturing market strategic initiatives analysis
Fig. 22 Semi-solid dosage contract manufacturing market: Type movement analysis
Fig. 23 Semi-solid dosage contract manufacturing market: Type outlook and key takeaways
Fig. 24 Topical market estimates and forecast, 2018 - 2030
Fig. 25 Transdermal market estimates and forecast, 2018 - 2030
Fig. 26 Oral market estimates and forecast, 2018 - 2030
Fig. 27 Semi-solid dosage contract manufacturing Market: Product movement analysis
Fig. 28 Semi-solid dosage contract manufacturing market: Product outlook and key takeaways
Fig. 29 Creams market estimates and forecasts, 2018 - 2030
Fig. 30 Immunoassay market estimates and forecasts, 2018 - 2030
Fig. 31 Ointments market estimates and forecasts, 2018 - 2030
Fig. 32 Gels market estimates and forecasts, 2018 - 2030
Fig. 33 Lotions market estimates and forecasts, 2018 - 2030
Fig. 34 Pastes market estimates and forecasts, 2018 - 2030
Fig. 35 Others market estimates and forecast, 2018 - 2030
Fig. 36 Semi-solid dosage contract manufacturing market: End Use movement analysis
Fig. 37 Semi-solid dosage contract manufacturing market: End Use outlook and key takeaways
Fig. 38 Pharmaceutical companies market estimates and forecast, 2018 - 2030
Fig. 39 Cosmeceutical companies market estimates and forecast, 2018 - 2030
Fig. 40 Others market estimates and forecast, 2018 - 2030
Fig. 41 Semi-solid dosage contract manufacturing market: End use movement analysis
Fig. 42 Semi-solid dosage contract manufacturing market: End use outlook and key takeaways
Fig. 43 Large size companies market estimates and forecasts, 2018 - 2030
Fig. 44 Medium & small size companies market estimates and forecasts, 2018 - 2030
Fig. 45 Others market estimates and forecasts, 2018 - 2030
Fig. 46 Global semi-solid dosage contract manufacturing market: Regional movement analysis
Fig. 47 Global semi-solid dosage contract manufacturing market: Regional outlook and key takeaways
Fig. 48 Global semi-solid dosage contract manufacturing market share and leading players
Fig. 49 North America market share and leading players
Fig. 50 Europe market share and leading players
Fig. 51 Asia Pacific market share and leading players
Fig. 52 Latin America market share and leading players
Fig. 53 Middle East & Africa market share and leading players
Fig. 54 North America, by country
Fig. 55 North America
Fig. 56 North America market estimates and forecasts, 2018 - 2030
Fig. 57 U.S. key country dynamics
Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
Fig. 59 Canada key country dynamics
Fig. 60 Canada market estimates and forecasts, 2018 - 2030
Fig. 61 Mexico key country dynamics
Fig. 62 Mexico market estimates and forecasts, 2018 - 2030
Fig. 63 Europe
Fig. 64 Europe market estimates and forecasts, 2018 - 2030
Fig. 65 UK key country dynamics
Fig. 66 UK market estimates and forecasts, 2018 - 2030
Fig. 67 Germany key country dynamics
Fig. 68 Germany market estimates and forecasts, 2018 - 2030
Fig. 69 France key country dynamics
Fig. 70 France market estimates and forecasts, 2018 - 2030
Fig. 71 Italy key country dynamics
Fig. 72 Italy market estimates and forecasts, 2018 - 2030
Fig. 73 Spain key country dynamics
Fig. 74 Spain market estimates and forecasts, 2018 - 2030
Fig. 75 Denmark key country dynamics
Fig. 76 Denmark market estimates and forecasts, 2018 - 2030
Fig. 77 Sweden key country dynamics
Fig. 78 Sweden market estimates and forecasts, 2018 - 2030
Fig. 79 Norway key country dynamics
Fig. 80 Norway market estimates and forecasts, 2018 - 2030
Fig. 81 Asia Pacific
Fig. 82 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 83 China key country dynamics
Fig. 84 China market estimates and forecasts, 2018 - 2030
Fig. 85 Japan key country dynamics
Fig. 86 Japan market estimates and forecasts, 2018 - 2030
Fig. 87 India key country dynamics
Fig. 88 India market estimates and forecasts, 2018 - 2030
Fig. 89 Thailand key country dynamics
Fig. 90 Thailand market estimates and forecasts, 2018 - 2030
Fig. 91 South Korea key country dynamics
Fig. 92 South Korea market estimates and forecasts, 2018 - 2030
Fig. 93 Australia key country dynamics
Fig. 94 Australia market estimates and forecasts, 2018 - 2030
Fig. 95 Latin America
Fig. 96 Latin America market estimates and forecasts, 2018 - 2030
Fig. 97 Brazil key country dynamics
Fig. 98 Brazil market estimates and forecasts, 2018 - 2030
Fig. 99 Argentina key country dynamics
Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
Fig. 101 Middle East and Africa
Fig. 102 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 103 South Africa key country dynamics
Fig. 104 South Africa market estimates and forecasts, 2018 - 2030
Fig. 105 Saudi Arabia key country dynamics
Fig. 106 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 107 UAE key country dynamics
Fig. 108 UAE market estimates and forecasts, 2018 - 2030
Fig. 109 Kuwait key country dynamics
Fig. 110 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 111 Market share of key market players- Semi-solid dosage contract manufacturing market

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030

Description

Table of Contents

List of Tables

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Semi-solid Dosage Contract Manufacturing Market Variables, Trends & Scope

Chapter 4. Semi-solid Dosage Contract Manufacturing Market: Type Estimates & Trend Analysis

Chapter 5. Semi-solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

Chapter 6. Semi-solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

Chapter 7. Semi-solid Dosage Contract Manufacturing Market: Company Size Estimates & Trend Analysis

Chapter 8. Semi-solid Dosage Contract Manufacturing Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures